Chargement en cours...
Prolonged therapy with cabazitaxel in an octogenarian with metastatic castration-resistant prostate cancer
In the phase III TROPIC trial, cabazitaxel in combination with prednisone was compared to mitoxantrone with prednisone in patients with metastatic castration-resistant disease (mCRPC) that had received previous therapy with docetaxel. Cabazitaxel therapy was associated with an improvement in overall...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2012
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3845876/ https://ncbi.nlm.nih.gov/pubmed/22575202 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clgc.2012.03.007 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|